André Brás Gonçalves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
André Brás Gonçalves has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
AndrÉ BrÀs GonÇalves
Department of Biology, University of Copenhagen, Denmark
1 shared publication- Beinta BiskopstØ Joensen
Department of Biology, University of Copenhagen, Denmark
1 shared publication - Carlo Rivolta
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, 4031, Switzerland
1 shared publication - Catja Weiss
Department of Biology, University of Copenhagen, Denmark
1 shared publication - Jens Skorstensgaard Andersen
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark
1 shared publication Konstantinos Nikopoulos
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland
1 shared publication
Latest Publications
- Open Access
CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels
CEP78 is a centrosomal protein implicated in ciliogenesis and ciliary length control, and mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss. However, the mechanism by which CEP78 affects cilia formation is unknown. Based on a recently discovered disease-causing CEP78 p.L150S mutation, we identified the disease-relevant interactome of CEP78. We confirmed that CEP78 interacts with the EDD1-DYRK2-DDB1 VPRBP E3 ubiquitin ligase complex, which is involved in CP110 ubiquitination and degradation, and identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78 L150S mutation. We show that CEP350 promotes centrosomal recruitment and stability of CEP78, which in turn leads to centrosomal recruitment of EDD1. Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal. We propose that CEP78 functions downstream of CEP350 to promote ciliogenesis by negatively regulating CP110 levels via an EDD1-dependent mechanism.
Open AccessCEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels
CEP78 is a centrosomal protein implicated in ciliogenesis and ciliary length control, and mutations in the CEP78 gene cause retinal cone-rod dystrophy associated with hearing loss. However, the mechanism by which CEP78 affects cilia formation is unknown. Based on a recently discovered disease-causing CEP78 p.L150S mutation, we identified the disease-relevant interactome of CEP78. We confirmed that CEP78 interacts with the EDD1-DYRK2-DDB1 VPRBP E3 ubiquitin ligase complex, which is involved in CP110 ubiquitination and degradation, and identified a novel interaction between CEP78 and CEP350 that is weakened by the CEP78 L150S mutation. We show that CEP350 promotes centrosomal recruitment and stability of CEP78, which in turn leads to centrosomal recruitment of EDD1. Consistently, cells lacking CEP78 display significantly increased cellular and centrosomal levels of CP110, and depletion of CP110 in CEP78-deficient cells restored ciliation frequency to normal. We propose that CEP78 functions downstream of CEP350 to promote ciliogenesis by negatively regulating CP110 levels via an EDD1-dependent mechanism.